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Coronavirus disease-2019 (COVID-19), caused by the severe acute respiratory distress syndrome coro-navirus-2 (SARS-CoV-2), started as an outbreak of pneumonia in Wuhan, China, in December 2019 and on March 11, 2020, the world health organization (WHO) declared it as a pandemic. Since then, 
COVID-19 has affected millions of people all around the world and has caused significant disruption of our 
physical, mental, and social health. COVID-19 vaccine is still a work in progress, and currently, social distanc-
ing and facemasks are the only few measures being used to prevent the spread of the virus.
While the northern hemisphere is on the verge of embracing the fall season, 
it means the next flu season seems not too far as well. According to a study 
by The Center for Disease Control and Prevention (CDC) and global health 
partners in 2017, up to 646 000 people die worldwide from influenza-re-
lated illnesses every year, and up to 72 000 of these deaths occur in Europe. 
The estimates of mortality from influenza have significantly gone up in the 
last few years [1]. Unfortunately, the flu season is going to be much more dif-
ferent and challenging this time due to the presence of COVID-19. It could 
lead to a substantial increase in morbidity and mortality.
The major difference, however, between influenza and COVID-19 is that we already have a vaccine available 
for the former. Influenza vaccines can prevent influenza infections and can also decrease the rate of hospital-
izations and deaths among the recipients, especially young children, older adults (>65 years), and pregnant 
women. As per the CDC estimates, more than 35.5 million cases, nearly 490 600 hospitalizations, and 34 200 
deaths were due to influenza during the 2018-2019 flu season in the United States [2]. Also, during the same 
2018-2019 season, the influenza vaccination rate was approximately 49%, which, according to the CDC, pre-
vented 4.4 million influenza illnesses, 58 000 hospitalizations, and around 3500 deaths [3]. It is quite clear 
that during the time of COVID-19, low influenza vaccination rates during the 2020-21 flu season could make 
these numbers significantly worse. This could seriously damage the efforts that are under way to control the 
COVID-19 pandemic by increasing health care demand and exhausting the available resources. This could 
further jeopardize and weaken adequate health care delivery.
But it has been a struggle to improve the influenza vaccination rate. Questions have always been raised about 
the effectiveness of the flu vaccine. It is estimated that the effectiveness of a flu vaccine is generally around 40%-
60% when the circulating viruses are well-matched [4]. Moreover, certain myths prevail and adversely affect 
vaccination rates. “One can catch flu from a flu vaccine,” “healthy persons do not need flu shots,” or even, “flu 
is not a serious disease” are just some of the examples of such false beliefs.
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A well-strategized influenza vaccina-
tion program could lessen the burden 
of the healthcare system and ensure an 
adequate healthcare delivery during the 
COVID-19 pandemic.
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CREATING AWARENESS ABOUT INFLUENZA VACCINATION
One question that could come to the mind of an epidemiologist, a health policymaker, or a health professional is 
if COVID-19 has created enough awareness that it could help improve the seasonal influenza vaccination rates.
A survey of 10 957 adults in the United States between April 29 to May 
5, 2020, showed that at least 28% of the adults knew someone who was 
diagnosed with COVID-19 and around 20% of them knew at least one 
person who had been hospitalized or even died due to COVID-19 [5]. 
Every day, there is plenty of new information that comes out regarding 
COVID-19, and it is not wrong to believe that the COVID-19 pandemic 
might have created awareness among the people, and that can prove to 
be useful when it comes to getting the flu vaccination. It is not hard to 
imagine that people are likely to be more receptive during this time of the pandemic, regarding influenza, its 
risks including hospitalization and pneumonia, and benefits of vaccination.
Is it safe, though, to assume that the psychological effects of the COVID-19 pandemic could help the way of 
clearing doubts among people who were reluctant to get a flu vaccine during the previous flu seasons?
STRATEGIES TO IMPROVE INFLUENZA VACCINATION RATES
Healthcare policymakers and health care professionals could come together and strategize a systemic approach 
to create awareness about the importance of flu vaccine. Social media and digital media platforms could prove 
useful for running campaigns regarding the benefits of getting vaccinated during the time of the COVID-19 
crisis. The general population should be explained about the myths surrounding the vaccines. A particular 
focus should be on the vulnerable population as well, such as children, older adults, and pregnant women.
Directing efforts towards improving health 
care access for safe vaccine administration 
should also be a priority. Since during the 
time of COVID-19 pandemic, health care 
providers are more likely to conduct vir-
tual visits via telehealth service, especial-
ly for regular physicals or annual visits, 
that platform could be utilized to remind 
the patients about flu vaccination. How-
ever, limiting clinic visits could decrease 
flu immunization rates as well. It must be 
ensured that safe access is created for pa-
tients to get flu shots. It is not difficult to 
organize a “drive-through” for patients to 
receive the flu vaccine, the similar way by 
which many clinics have executed plans 
for COVID-19 testing. “Flu vaccination 
drive” or such events could be arranged with proper safety precautions (masks, temperature checks, sanitiz-
ers) at certain businesses, workplaces, nursing homes, hospitals, schools, colleges, or places of worship if they 
remain open during this time. Help from local outpatient pharmacies could be undertaken to accomplish such 
vaccine drives. Healthcare policymakers should also look into creating mandates for requiring flu vaccinations 
at a broader level or even at smaller scale targeting health care facilities, nursing homes, schools, or essential 
businesses. It should be ascertained that the vaccine availability and production are at par to meet the increase 
in demands. Vaccine costs should not become an obstacle for those individuals who are in economic hardship 
due to the COVID-19 situation.
CAN WE SUCCEED IN PREVENTING ANOTHER EPIDEMIC?
We are eagerly waiting for the COVID-19 vaccine because, in addition to the social distancing and use of masks 
to prevent the spread of the virus, a vaccine is something that can restore normalcy across the world. A survey 
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ly or probably get COVID-19 vaccine when it comes out [6], Based on the same rationalization, it should not 
be difficult to convince people to get the flu vaccine. On a positive side, the efforts that we put for improving 
flu vaccination at this time will surely be equally helpful when the COVID-19 vaccine rolls out in the future.
In the era of the socio-digital world, it is not hard to believe that a process such as creating awareness about flu 
vaccination cannot gain momentum. Generous participation of people, the dedication of health care profes-
sionals, and the political will of policymakers are all it may take to prevent another epidemic during this time! 
Improving influenza vaccination rates will not only improve morbidity and mortality related to influenza but 
will also spare the already overburdened health system in the time COVID-19 and maintain its proper func-
tioning without exhausting the resources. While our eyes are on the researchers to come out with a COVID-19 
vaccine rather quickly, it should not look too difficult for all of us, who have experienced a lot in the last few 
months, to try and prevent another epidemic with a simple and safe vaccine. This is not the time to ask, “If or 
when can we act?” but rather “How and now!”
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